Evaluation of the safety and efficacy of a virus-like particle vaccine for prevention of chikungunya virus disease

Active Project Grant Awarded Last action

Award ID
W81XWH2210481
Recipient
Awarding agency
Obligated
$1,757,856

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 78% complete
Originally
Funding
  • $1,542,311.26 Federal
  • $215,544.26 Non-federal
Place of performance
Denmark

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $1,326,767 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Original award $215,544 $215,544

Subawards

Subrecipient Amount Awarded
University Of Notre Dame DU Lac Work performed under this Statement of Work will be partially supported by a federal research award from the Peer Reviewed Medical Research Program. The… $613,173
Emory University Evaluation of the Safety and Efficacy of a Virus-Like Particle Vaccine for Prevention of Chikungunya Virus Disease” (Award W81XWH2210481). $181,156

Quick answers

Who received award W81XWH2210481?

W81XWH2210481 was awarded to Bavarian Nordic A / S by Defense Health Agency (Department of Defense) on September 1, 2022.

How much is award W81XWH2210481 worth?

$1,757,856 has been obligated on W81XWH2210481: $1,542,311 in federal funding and $215,544 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award